Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies
Dominic Schmid(German Cancer Research Center), Tobias Keßler(German Cancer Research Center)
Cited by 43
Related Papers
A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1
|Nature Communications|2024|45
Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphoma
|Blood|2024|27
A hitchhiker’s guide to cerebrospinal fluid biomarkers for neuro-oncology
|Neuro-Oncology|2024|15